CapeRay Medical (Pty) Ltd, based in Cape Town, South Africa, is a manufacturer of medical imaging equipment for the diagnosis of breast cancer. The company was founded in 2010 as a spinoff from the University of Cape Town (UCT) and received a substantial investment from the Industrial Development Corporation of South Africa. CapeRay's flagship product, Aceso, is a dual-modality imaging system that combines low dose digital x-rays and automated breast ultrasound to provide complementary information for the early diagnosis of breast cancer, particularly in women with dense breast tissue. It has been awarded the ISO 13485 certification and the CE Mark for its Aceso system. The most recent investment, a ZAR15.00M Series C investment on 01 December 2015, signifies ongoing support for the company's innovative approach to breast cancer diagnosis within the Manufacturing and Medical Devices industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series C | ZAR15.00M | - | 01 Dec 2015 | |
| Venture Round | $2.00M | - | 24 Aug 2010 |
No recent news or press coverage available for CapeRay.
We care about your data, and we'd love to use cookies make your experience better.
